Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

December 01, 2015 2:10 AM ET


Company Overview of Pharming Group NV

Executive Profile

J. Barrie Ward Ph.D.

Member of Supervisory Board, Chairman of Remuneration Committee, Chairman of Corporate Governance Committee and Member of Audit Committee, Pharming Group NV
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 10 different industries.

See Board Relationships


Dr. J. Barrie Ward, Ph.D., served as Chief Executive Officer of KuDOS Pharmaceuticals Limited from 1999 to January 2006. Dr. Ward has experience in extensive scientific and business of Kudos Pharmaceuticals Limited. He served as Chairman and Chief Executive Officer of Virus Research Institute Inc., Cambridge MA from July 1994 to August 1998. From 1984 to June 1994, he served as Director of the Microbiology Division of Glaxo Research and Development, with responsibility ...

Corporate Headquarters

Darwinweg 24
Leiden, Zuid-Holland 2333 CR


Phone: 31 71 524 7400
Fax: 31 71 524 7445

Board Members Memberships

Non Executive Director


University of Bath
University of Bath

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation€40,000
Total Calculated Compensation€44,000

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Jon P. Stonehouse Chief Executive Officer, President and Executive Director
BioCryst Pharmaceuticals, Inc.
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
John Dawson Chief Executive Officer and Executive Director
Oxford BioMedica PLC
Edwin Moses Ph.D.Chief Executive Officer, Director and Member of Research & Development Committee
Ablynx NV
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Pharming Group NV, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at